5 of Last Week's Biggest Winners

These five stocks posted double-digit percentage gains.

Apr 13, 2014 at 8:00AM

It was a rocky week on Wall Street, with Nasdaq stocks inching lower and the Dow inching higher, but there were plenty of stocks really making some serious moves. Let's take a closer look at five of this past week's biggest scorchers.


April 11

Weekly Gain

Titan Machinery (NASDAQ:TITN)



Thompson Creek Metals (NYSE:TC)



Questcor Pharmaceuticals (NASDAQ:QCOR)



Constant Contact (NASDAQ:CTCT)



Rite Aid (NYSE:RAD)



Source: Barron's.

Let's start with Titan Machinery. The retailer of agricultural gear shot higher after blowing Wall Street's profit targets out of the water. Revenue declined nearly 10% in its latest quarter, and adjusted earnings fell sharply to $0.35 a share. This report may not seem like much of a catalyst for a rally, but assessing every crop harvest is always based on expectations. In Titan's case, analysts were only forecasting a profit of $0.20 a share.

Thompson Creek Metals moved higher after announcing that concentrate production for Mt. Milligan clocked in at 28,200 dry metric tons, correcting a press release that initially pegged the production at 22,200 dry metric tons. Expanding from its roots in molybdenum, Thompson Creek sported healthy sequential growth in gold and copper production in its latest quarter.

Questcor Pharmaceuticals moved higher after receiving a buyout bid that values the drug maker at nearly $5.6 billion. Questcor has been a popular short lately, but clearly there's an Irish pharmaceuticals giant that believes in Questcor's existing drugs and the potential for its Acthar gel that's aiming to tackle the treatment of Lou Gehrig's disease.

Constant Contact is a mailing list manager for companies and website operators to update followers. It updated the market this past week by issuing a preliminary peek at its latest quarter that suggests market-thumping results during the past three months. Dougherty & Company upgraded Constant Contact on the news.

Finally we have Rite Aid doing everything right in its latest report. The drugstore chain came through with a quarterly profit of $0.06 a share. Analysts were settling for net income of just $0.04 a share. This is no longer a matter of a turnaround. After rattling off several profitable quarters in a row it's safe to say that the drugstore operator is back. Rite Aid's guidance also clocked in stronger than the pros were projecting.

Keep the winners coming
One of the dirty secrets that few finance professionals will openly admit is that dividend stocks as a group handily outperform their non-dividend-paying brethren. However, knowing this is only half the battle. The other half is identifying which dividend stocks in particular are the best. With this in mind, our top analysts put together a free list of nine high-yielding stocks that should be in every income investor's portfolio. To learn the identity of these stocks instantly and for free, all you have to do is click here now.

Rick Munarriz and The Motley Fool own no shares in this article. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

4 in 5 Americans Are Ignoring Buffett's Warning

Don't be one of them.

Jun 12, 2015 at 5:01PM

Admitting fear is difficult.

So you can imagine how shocked I was to find out Warren Buffett recently told a select number of investors about the cutting-edge technology that's keeping him awake at night.

This past May, The Motley Fool sent 8 of its best stock analysts to Omaha, Nebraska to attend the Berkshire Hathaway annual shareholder meeting. CEO Warren Buffett and Vice Chairman Charlie Munger fielded questions for nearly 6 hours.
The catch was: Attendees weren't allowed to record any of it. No audio. No video. 

Our team of analysts wrote down every single word Buffett and Munger uttered. Over 16,000 words. But only two words stood out to me as I read the detailed transcript of the event: "Real threat."

That's how Buffett responded when asked about this emerging market that is already expected to be worth more than $2 trillion in the U.S. alone. Google has already put some of its best engineers behind the technology powering this trend. 

The amazing thing is, while Buffett may be nervous, the rest of us can invest in this new industry BEFORE the old money realizes what hit them.

KPMG advises we're "on the cusp of revolutionary change" coming much "sooner than you think."

Even one legendary MIT professor had to recant his position that the technology was "beyond the capability of computer science." (He recently confessed to The Wall Street Journal that he's now a believer and amazed "how quickly this technology caught on.")

Yet according to one J.D. Power and Associates survey, only 1 in 5 Americans are even interested in this technology, much less ready to invest in it. Needless to say, you haven't missed your window of opportunity. 

Think about how many amazing technologies you've watched soar to new heights while you kick yourself thinking, "I knew about that technology before everyone was talking about it, but I just sat on my hands." 

Don't let that happen again. This time, it should be your family telling you, "I can't believe you knew about and invested in that technology so early on."

That's why I hope you take just a few minutes to access the exclusive research our team of analysts has put together on this industry and the one stock positioned to capitalize on this major shift.

Click here to learn about this incredible technology before Buffett stops being scared and starts buying!

David Hanson owns shares of Berkshire Hathaway and American Express. The Motley Fool recommends and owns shares of Berkshire Hathaway, Google, and Coca-Cola.We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

©1995-2014 The Motley Fool. All rights reserved. | Privacy/Legal Information